Wealth Preservation Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$154K Buy
2,543
+147
+6% +$8.57K 0.13% 78
2025
Q4
$129K Buy
2,396
+12
+0.5% +$577 0.07% 117
2025
Q3
$108K Sell
2,384
-33
-1% -$1.54K 0.06% 128
2025
Q2
$112K Hold
2,417
0.07% 124
2025
Q1
$147K Buy
+2,417
New +$141K 0.11% 96

Other funds holding BMY

Wealth Preservation Advisors's BMY Position: Q1 2026 in Review

Wealth Preservation Advisors increased its Bristol-Myers Squibb (BMY) stake by 6.1% in Q1 2026, buying an estimated $8.57K and bringing the position to 2,543 shares worth $154K. The position accounts for 0.13% of the portfolio, ranked #78.

Wealth Preservation Advisors first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Wealth Preservation Advisors held 2,543 shares of Bristol-Myers Squibb worth $154K as of Q1 2026.
  • Wealth Preservation Advisors bought 147 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.57K.
  • Bristol-Myers Squibb made up 0.13% of Wealth Preservation Advisors's portfolio in Q1 2026, its #78 holding.
  • Wealth Preservation Advisors first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.